Panagiotis Efentakis

1.8k total citations
46 papers, 948 citations indexed

About

Panagiotis Efentakis is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Panagiotis Efentakis has authored 46 papers receiving a total of 948 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Cardiology and Cardiovascular Medicine and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Panagiotis Efentakis's work include Cardiac Ischemia and Reperfusion (10 papers), Multiple Myeloma Research and Treatments (8 papers) and Chemotherapy-induced cardiotoxicity and mitigation (7 papers). Panagiotis Efentakis is often cited by papers focused on Cardiac Ischemia and Reperfusion (10 papers), Multiple Myeloma Research and Treatments (8 papers) and Chemotherapy-induced cardiotoxicity and mitigation (7 papers). Panagiotis Efentakis collaborates with scholars based in Greece, Germany and Italy. Panagiotis Efentakis's co-authors include Ioanna Andreadou, Efstathios K. Iliodromitis, Panagiota Nikolaou, Nikolaos Kostomitsopoulos, Aimilia Varela, Constantinos H. Davos, Andreas Papapetropoulos, Andreas Daiber, George Dimitriadis and Ignatios Ikonomidis and has published in prestigious journals such as Blood, Free Radical Biology and Medicine and International Journal of Molecular Sciences.

In The Last Decade

Panagiotis Efentakis

44 papers receiving 942 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Panagiotis Efentakis Greece	20	376	221	189	178	174	46	948
Mirco Zucchelli Italy	20	681 1.8×	219 1.0×	210 1.1×	129 0.7×	138 0.8×	38	1.5k
Stacey Ruiz United States	8	937 2.5×	137 0.6×	215 1.1×	158 0.9×	128 0.7×	12	1.7k
Dongdan Zheng China	21	402 1.1×	293 1.3×	77 0.4×	115 0.6×	178 1.0×	30	1.2k
Tamehachi Namikoshi Japan	18	306 0.8×	187 0.8×	132 0.7×	199 1.1×	141 0.8×	25	1.3k
Yuko Izuhara Japan	19	310 0.8×	154 0.7×	259 1.4×	128 0.7×	136 0.8×	33	1.4k
Yoshisuke Haruna Japan	17	441 1.2×	266 1.2×	227 1.2×	145 0.8×	167 1.0×	23	1.6k
Haruhisa Otani Japan	18	460 1.2×	110 0.5×	155 0.8×	155 0.9×	453 2.6×	46	1.5k
Carola Doerries Germany	10	575 1.5×	388 1.8×	254 1.3×	86 0.5×	296 1.7×	11	1.3k
Maurizio Degan Italy	20	326 0.9×	345 1.6×	122 0.6×	135 0.8×	165 0.9×	58	1.2k

Countries citing papers authored by Panagiotis Efentakis

Since Specialization

Citations

This map shows the geographic impact of Panagiotis Efentakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Panagiotis Efentakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Panagiotis Efentakis more than expected).

Fields of papers citing papers by Panagiotis Efentakis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Panagiotis Efentakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Panagiotis Efentakis. The network helps show where Panagiotis Efentakis may publish in the future.

Co-authorship network of co-authors of Panagiotis Efentakis

This figure shows the co-authorship network connecting the top 25 collaborators of Panagiotis Efentakis. A scholar is included among the top collaborators of Panagiotis Efentakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Panagiotis Efentakis. Panagiotis Efentakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Efentakis, Panagiotis, Panagiota Nikolaou, Nikolaos Kostomitsopoulos, et al.. (2025). Cardioprotection Through Pharmacological Activation of Sirtuin 5 in a Murine Model of Acute Myocardial Infarction. Drug Design Development and Therapy. Volume 19. 5489–5505. 1 indexed citations

Efentakis, Panagiotis, Grzegorz Kwiatkowski, Aimilia Varela, et al.. (2024). Early microvascular coronary endothelial dysfunction precedes pembrolizumab-induced cardiotoxicity. Preventive role of high dose of atorvastatin. Basic Research in Cardiology. 120(1). 263–286. 18 indexed citations

Efentakis, Panagiotis, Nikolaos Kostomitsopoulos, Alexios‐Léandros Skaltsounis, et al.. (2023). Synergistic Pulmonoprotective Effect of Natural Prolyl Oligopeptidase Inhibitors in In Vitro and In Vivo Models of Acute Respiratory Distress Syndrome. International Journal of Molecular Sciences. 24(18). 14235–14235. 3 indexed citations

Efentakis, Panagiotis, Maria Gavriatopoulou, Meletios Α. Dimopoulos, et al.. (2023). Metabolomics Point out the Effects of Carfilzomib on Aromatic Amino Acid Biosynthesis and Degradation. International Journal of Molecular Sciences. 24(18). 13966–13966.

Nikolaou, Panagiota, Manousos Makridakis, Marina Makrecka‐Kuka, et al.. (2022). Cardioprotection by selective SGLT-2 inhibitors in a non-diabetic mouse model of myocardial ischemia/reperfusion injury: a class or a drug effect?. Basic Research in Cardiology. 117(1). 27–27. 39 indexed citations

Efentakis, Panagiotis, Michael Molitor, Sabine Kossmann, et al.. (2021). Tubulin-folding cofactor E deficiency promotes vascular dysfunction by increased endoplasmic reticulum stress. European Heart Journal. 43(6). 488–500. 9 indexed citations

Tsoumani, Maria, Anastasios D. Georgoulis, Panagiota Nikolaou, et al.. (2021). Acute administration of the olive constituent, oleuropein, combined with ischemic postconditioning increases myocardial protection by modulating oxidative defense. Free Radical Biology and Medicine. 166. 18–32. 22 indexed citations

Ikonomidis, Ignatios, Dimitrios Vlastos, Ioanna Andreadou, et al.. (2021). Vascular conditioning prevents adverse left ventricular remodelling after acute myocardial infarction: a randomised remote conditioning study. Basic Research in Cardiology. 116(1). 9–9. 26 indexed citations

Efentakis, Panagiotis, Aimilia Varela, Eleni‐Dimitra Papanagnou, et al.. (2021). Elucidating Carfilzomib’s Induced Cardiotoxicity in an In Vivo Model of Aging: Prophylactic Potential of Metformin. International Journal of Molecular Sciences. 22(20). 10956–10956. 11 indexed citations

10.

Nikolaou, Panagiota, Panagiotis Efentakis, Saveria Femminò, et al.. (2020). Chronic Empagliflozin Treatment Reduces Myocardial Infarct Size in Nondiabetic Mice Through STAT-3-Mediated Protection on Microvascular Endothelial Cells and Reduction of Oxidative Stress. Antioxidants and Redox Signaling. 34(7). 551–571. 65 indexed citations

11.

Efentakis, Panagiotis, Aimilia Varela, Constantinos H. Davos, et al.. (2017). Comparison of Proteasome Inhibitors-Induced Cardiotoxicity (carfilzomib vs. bortezomib): Insights into the Molecular Mechanisms. Blood. 130. 3086–3086. 1 indexed citations

12.

Andreadou, Ioanna, Panagiotis Efentakis, Evangelos Balafas, et al.. (2017). Empagliflozin Limits Myocardial Infarction in Vivo and Cell Death in Vitro: Role of STAT3, Mitochondria, and Redox Aspects. Frontiers in Physiology. 8. 1077–1077. 125 indexed citations

13.

Efentakis, Panagiotis, Anna Rizakou, Eirini Christodoulou, et al.. (2017). Saffron ( Crocus sativus ) intake provides nutritional preconditioning against myocardial ischemia–reperfusion injury in Wild Type and ApoE (−/−) mice: Involvement of Nrf2 activation. Nutrition Metabolism and Cardiovascular Diseases. 27(10). 919–929. 34 indexed citations

14.

Sigala, Fragiska, Panagiotis Efentakis, Konstantinos Filis, et al.. (2017). Reciprocal regulation of eNOS, H2S and CO-synthesizing enzymes in human atheroma: Correlation with plaque stability and effects of simvastatin. Redox Biology. 12. 70–81. 28 indexed citations

15.

Andreadou, Ioanna, Sofia Mitakou, S Paraschos, et al.. (2016). “Pistacia lentiscus L.” reduces the infarct size in normal fed anesthetized rabbits and possess antiatheromatic and hypolipidemic activity in cholesterol fed rabbits. Phytomedicine. 23(11). 1220–1226. 28 indexed citations

16.

Poudyal, Hemant, Panagiotis Efentakis, Evagelos Gikas, et al.. (2016). Hydroxytyrosol ameliorates metabolic, cardiovascular and liver changes in a rat model of diet-induced metabolic syndrome: Pharmacological and metabolism-based investigation. Pharmacological Research. 117. 32–45. 42 indexed citations

17.

Chatzianastasiou, Athanasia, Ioanna Andreadou, Panagiotis Efentakis, et al.. (2016). Cardioprotection by H2S Donors: Nitric Oxide-Dependent and ‑Independent Mechanisms. Journal of Pharmacology and Experimental Therapeutics. 358(3). 431–440. 78 indexed citations

18.

Efentakis, Panagiotis, Ioanna Andreadou, Nikolaos Dagres, et al.. (2016). Ranolazine triggers pharmacological preconditioning and postconditioning in anesthetized rabbits through activation of RISK pathway. European Journal of Pharmacology. 789. 431–438. 9 indexed citations

19.

Lougiakis, Nikolaos, Andreas Papapetropoulos, Evagelos Gikas, et al.. (2016). Synthesis and Pharmacological Evaluation of Novel Adenine–Hydrogen Sulfide Slow Release Hybrids Designed as Multitarget Cardioprotective Agents. Journal of Medicinal Chemistry. 59(5). 1776–1790. 26 indexed citations

20.

Andreadou, Ioanna, Sofia‐Iris Bibli, Αναστασία Ζώγα, et al.. (2015). Transient carotid ischemia as a remote conditioning stimulus for myocardial protection in anesthetized rabbits: Insights into intracellular signaling. International Journal of Cardiology. 184. 140–151. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact